Biocure Technology, Inc. engages in the development and commercialization of biosimilar products. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2008-03-27. The firm specializes in the development and commercialization of its own CAR T-cell therapy, targeting Chronic lymphocytic leukemia and solid tumor cancers. Additionally, the Company is developing biosimilar technologies for cancer treatment. The Company’s products include Interferon Beta, Ranibizumab and PEG-Filgrastim.
BICTF stock price ended at $0.01 on 水曜日, after rising Infinity%
On the latest trading day May 14, 2025, the stock price of BICTF rose by Infinity%, climbing from $0.01 to $0.01. During the session, the stock saw a volatility of 0.00%, with prices oscillating between a daily low of $0.01 and a high of $0.01. Notably, trading volume dropped by 38.7K shares on the last day despite the price increase, which may signal a potential uptick in risk in the near term. A total of 39.0K shares were traded, equating to a market value of approximately $154.4K.
Teknik analiz göstergeleri BICTF için nasıl uygulanır?
Teknik analize göre, Biocure Technology Inc Neutral toplam sinyaline sahiptir. Biocure Technology Inc 0 adet al sinyali, 7 adet nötr sinyal ve 0 adet sat sinyali vardır.
BICTF için Fibonacci geri dönüş seviyeleri nelerdir?
Biocure Technology Inc için Fibonacci geri dönüş seviyesi 0%と23.6%の間dir。
Biocure Technology Inc için RSI nedir?
Biocure Technology Inc için mevcut RSI NaN 'dir, bu da 中立 durumunu gösterir
Önümüzdeki 12 ay için Biocure Technology Inc fiyatı nedir?
Biocure Technology Inc BICTF önümüzdeki 12 ay için $0 olarak tahmin edilmektedir.
Biocure Technology Inc ne kadar yükselmesi bekleniyor?
Wall Street analistlerine göre, Biocure Technology Inc $0 yüksek tahminine ulaşması beklenmektedir.